View All Key Stats
VVUS Key Stats
| Income Statement | |
| Revenue (TTM) | 56.89M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -4.04 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -42.52M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 80.74% |
| Profit Margin (Quarterly) | -50.99% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 29.87M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.5241 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -8.53M |
| Return on Equity (TTM) | Upgrade |
View All VVUS News
VVUS News
-
WireHeadlineTime (ET)
-
SA Breaking News12/07 12:48
-
SA Breaking News12/07 12:30
-
Yahoo12/01 09:31
-
Globe Newswire11/15 08:25
-
Yahoo11/07 07:16
-
Yahoo11/02 11:31
-
Yahoo11/01 19:36
-
SA Breaking News11/01 16:20
-
Globe Newswire11/01 16:10
-
Globe Newswire10/29 07:30
View All Events
VVUS Events
| Date | Type | Description |
|---|---|---|
| 05/08/2019 16:30 EDT | Misc | VIVUS Inc First Quarter Earnings Conference Call in 2019 |
| 03/13/2019 | Earnings | VIVUS Inc Fourth Quarter Earnings Results in 2018 |
| 11/01/2018 16:30 EDT | Misc | VIVUS Inc Third Quarter Earnings Conference Call in 2018 |
| 11/01/2018 | Earnings | VIVUS Inc Third Quarter Earnings in 2018 Release |
| 09/11/2018 | Splits | Ratio: 1:10 |
| 09/07/2018 | Misc | VIVUS Inc Annual General Meeting in 2017 |
| 08/07/2018 16:30 EDT | Misc | VIVUS Inc Second Quarter Earnings Conference Call in 2018 |
| 08/07/2018 | Earnings | VIVUS Inc Second Quarter Earnings in 2018 Release |
| 05/08/2018 16:30 EDT | Misc | VIVUS Inc First Quarter Earnings Conference Call in 2018 |
| 05/08/2018 | Earnings | VIVUS Inc First Quarter Earnings Results in 2018 |
VVUS Fundamentals
Income Statement View Statement
VVUS Ratings
Advertisement
VVUS One Page Reports
- One Page Report Download
VVUS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.81 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.vivus.com
- Investor Relations URL: http://ir.vivus.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Mar. 13, 2019
- Last Earnings Release: Nov. 01, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
VVUS Excel Add-In Codes
- Name: =YCI("VVUS","name")
- Description: =YCI("VVUS","description")
- Sector: =YCI("VVUS","sector")
- Industry: =YCI("VVUS","industry")
- Est. Current Fiscal Year End: =YCI("VVUS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VVUS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VVUS Tweets Stocktwits
Advertisement
